Page 3 - Sight Sciences Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Profitability This table compares Sight Sciences and […]

Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk. Valuation & Earnings This table compares Sight […]

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 969,700 shares, a drop of 20.5% from the October 31st total of 1,220,000 shares. Based on an average daily volume of 449,400 shares, the days-to-cover ratio is presently 2.2 […]

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 1,040,000 shares, an increase of 47.7% from the September 30th total of 704,000 shares. Based on an average daily volume of 234,900 shares, the short-interest ratio […]

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totalling 710,900 shares, an increase of 41.8% from the August 31st total of 501,200 shares. Based on an average daily volume of 196,300 shares, the short-interest ratio […]